Israel • Intellectual property
2

Intellectual property: commercial/transactions

Horn & Co

Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:

Herzog Fox & Neeman logo
Herzog Fox & Neeman
Seligsohn Gabrieli & Co logo
Seligsohn Gabrieli & Co
S. Horowitz & Co logo
S. Horowitz & Co
Horn & Co is a highly experienced advisor to clients in the technology space, trusted by a client lineup that includes young startups and publicly traded multinationals across various innovative sectors like software and pharma. The team operates under the direction of ‘knowledgeable and meticulous’ Yuval Horn, who is well-versed in advising tech-based companies and investors in IP-centric transactions, mergers, IPOs, restructurings, and more. Keren Kanir is particularly active in assisting clients from the med-tech sector.
Legal 500 redaktioneller Kommentar

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘Horn & Co. demonstrated an unparalleled depth of knowledge and expertise in the acquisition and financing transactions where they represented the fund. The team's ability to navigate complex legal intricacies with precision and insight was truly impressive. They approached every aspect of the transaction with meticulous attention to detail, ensuring all elements were thoroughly analysed and addressed.'

  • ‘Yuval Horn consistently delivers exceptional client service, marked by attentiveness, professionalism, and a proactive approach to addressing client needs. His sophisticated legal acumen, combined with keen commercial awareness and a visionary outlook, provides strategic counsel that not only resolves immediate legal issues but also anticipates future challenges and opportunities.'

Kernmandanten

  • The INX Digital Company, Inc.
  • Vascular Biogenics Ltd.

Highlight-Mandate

  • Advising INX Digital Company, Inc. in a series of agreements with Republic for a multi-step financial and commercial collaboration.
  • Assisting in a merger between Vascular Biogenics Ltd. and Notable Labs, Inc. after which Notable Labs will merge into a wholly owned subsidiary of VBL.